Human mesothelioma samples show a positive correlation between GLI1 and CK2α expression, and CK2α genetic silencing or pharmacological inhibition with the small-molecule CK2α inhibitor CX-4945 reduces the expression and transcriptional activity of GLI1 [73]. This evidence concerns the gene GLI1 and mesothelioma.